SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-015849
Filing Date
2021-08-05
Accepted
2021-08-05 16:10:23
Documents
43
Period of Report
2021-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nltx-20210805.htm   iXBRL 8-K 33866
2 EX-99.1 ex-991xpressreleaseofneole.htm EX-99.1 55528
3 EX-99.2 ex992-corporatepresentat.htm EX-99.2 24428
7 GRAPHIC ex992-corporatepresentat001.jpg GRAPHIC 48923
8 GRAPHIC ex992-corporatepresentat002.jpg GRAPHIC 225689
9 GRAPHIC ex992-corporatepresentat003.jpg GRAPHIC 108562
10 GRAPHIC ex992-corporatepresentat004.jpg GRAPHIC 145087
11 GRAPHIC ex992-corporatepresentat005.jpg GRAPHIC 102626
12 GRAPHIC ex992-corporatepresentat006.jpg GRAPHIC 103266
13 GRAPHIC ex992-corporatepresentat007.jpg GRAPHIC 111357
14 GRAPHIC ex992-corporatepresentat008.jpg GRAPHIC 80492
15 GRAPHIC ex992-corporatepresentat009.jpg GRAPHIC 119286
16 GRAPHIC ex992-corporatepresentat010.jpg GRAPHIC 135061
17 GRAPHIC ex992-corporatepresentat011.jpg GRAPHIC 134699
18 GRAPHIC ex992-corporatepresentat012.jpg GRAPHIC 122705
19 GRAPHIC ex992-corporatepresentat013.jpg GRAPHIC 121147
20 GRAPHIC ex992-corporatepresentat014.jpg GRAPHIC 158639
21 GRAPHIC ex992-corporatepresentat015.jpg GRAPHIC 110179
22 GRAPHIC ex992-corporatepresentat016.jpg GRAPHIC 135294
23 GRAPHIC ex992-corporatepresentat017.jpg GRAPHIC 93473
24 GRAPHIC ex992-corporatepresentat018.jpg GRAPHIC 92295
25 GRAPHIC ex992-corporatepresentat019.jpg GRAPHIC 124656
26 GRAPHIC ex992-corporatepresentat020.jpg GRAPHIC 103794
27 GRAPHIC ex992-corporatepresentat021.jpg GRAPHIC 104497
28 GRAPHIC ex992-corporatepresentat022.jpg GRAPHIC 112328
29 GRAPHIC ex992-corporatepresentat023.jpg GRAPHIC 100007
30 GRAPHIC ex992-corporatepresentat024.jpg GRAPHIC 107884
31 GRAPHIC ex992-corporatepresentat025.jpg GRAPHIC 102868
32 GRAPHIC ex992-corporatepresentat026.jpg GRAPHIC 101538
33 GRAPHIC ex992-corporatepresentat027.jpg GRAPHIC 80888
34 GRAPHIC ex992-corporatepresentat028.jpg GRAPHIC 50994
35 GRAPHIC image_0a.jpg GRAPHIC 14539
  Complete submission text file 0001628280-21-015849.txt   4611332

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nltx-20210805.xsd EX-101.SCH 1962
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nltx-20210805_lab.xml EX-101.LAB 24137
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nltx-20210805_pre.xml EX-101.PRE 12569
36 EXTRACTED XBRL INSTANCE DOCUMENT nltx-20210805_htm.xml XML 10551
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 211148247
SIC: 2834 Pharmaceutical Preparations